Search

Author/Creator Ganly, Peter

1. Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial. Issue 5 (May 2017)

Authors:
Mesa, Ruben A; Vannucchi, Alessandro M; Mead, Adam; Egyed, Miklos; Szoke, Anita; Suvorov, Aleksandr; Jakucs, Janos; Perkins, Andrew; Prasad, Ritam; Mayer, Jiri; Demeter, Judit; Ganly, Peter; Singer, Jack W; Zhou, Huafeng; Dean, James P; te Boekhorst, Peter A; Nangalia, Jyoti; Kiladjian, Jean-Jacq...
Journal:
Lancet
Issue:
Volume 4:Issue 5(2017)
Page Start:
e225
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma. Issue 22 (1st August 2021)

Authors:
Richardson, Paul G.; Kumar, Shaji K.; Masszi, Tamás; Grzasko, Norbert; Bahlis, Nizar J.; Hansson, Markus; Pour, Luděk; Sandhu, Irwindeep; Ganly, Peter; Baker, Bartrum W.; Jackson, Sharon R.; Stoppa, Anne-Marie; Gimsing, Peter; Garderet, Laurent; Touzeau, Cyrille; Buadi, Francis K.; Laubach, Jacob...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 22(2021)
Page Start:
2430
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. C‐MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide‐dexamethasone in myeloma. (15th April 2020)

Authors:
Di Bacco, Alessandra; Bahlis, Nizar J.; Munshi, Nikhil C.; Avet‐Loiseau, Hervé; Masszi, Tamás; Viterbo, Luísa; Pour, Ludek; Ganly, Peter; Cavo, Michele; Langer, Christian; Kumar, Shaji K.; Rajkumar, S. Vincent; Keats, Jonathan J.; Berg, Deborah; Lin, Jianchang; Li, Bin; Badola, Sunita; Shen, Lei;...
Journal:
European journal of haematology
Issue:
Volume 105:Number 1(2020)
Page Start:
35
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Development of T-cell lymphomas with an activated cytotoxic immunophenotype, including anaplastic large cell lymphomas, in patients with chronic lymphocytic leukemia: a series of six cases. Issue 3 (March 2015)

Authors:
Mant, Sarah; Taylor, Graeme; Dutton, David; Butler, Andrew; Browett, Peter; Ganly, Peter
Journal:
Leukemia & lymphoma
Issue:
Volume 56:Issue 3(2015:Mar.)
Page Start:
774
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗